Desmopressin patient safety alert
A patient safety alert has been issued by NHS England to raise awareness of the risk of severe dehydration and death caused by an omission or delay of desmopressin in patients with cranial diabetes insipidus. Following reports of patient safety incidents caused by an omission or delay in the provision of desmopressin, providers of NHS care are asked to consider if immediate action needs to be taken locally to raise awareness and reduce the risk of these incidents from occurring. The full alert can be found on the NHS England website.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20200687
Recommended from Pharmaceutical Press
- Previous
- Next
Patient Care in Community Practice
Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.
£22.00Buy now
Pharmaceutical Toxicology
Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.
£40.00Buy now
Introduction to Renal Therapeutics
Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.
£38.00Buy now
Traditional Medicine
Covers the major traditional medicine systems. Gives information on philosophy, practice, safety, evidence and examples.
£43.00Buy now
Integrated Pharmacy Case Studies
Over 90 case studies based on real life patient-care scenarios. Each case includes learning outcomes and references.
£47.00Buy now
Print 
PDF
Have your say
For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.